{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:39:26Z","timestamp":1786117166789,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jogc.2026.103404","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:44:53Z","timestamp":1779839093000},"page":"103404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Could Aspirin Be a Protective Factor and a Factor Promoting Placental Abruption?"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-4369","authenticated-orcid":false,"given":"Emmanuel","family":"Bujold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kypros H.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2026.103404_bib1","doi-asserted-by":"crossref","first-page":"S1313","DOI":"10.1016\/j.ajog.2022.06.059","article-title":"Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management","volume":"228","author":"Brandt","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2026.103404_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000342109","article-title":"Second-trimester uterine artery Doppler in the prediction of stillbirths","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2026.103404_bib3","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2026.103404_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2026.103404_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ajog.2025.10.032","article-title":"The effect of aspirin on the risk of preeclampsia based on the Fetal Medicine Foundation first-trimester risk","volume":"234","author":"Bujold","year":"2026","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2026.103404_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2026.103404_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/1471-0528.18211","article-title":"Impact of aspirin on timing of birth in pregnancies with clinical manifestations of placental dysfunction: evidence from a multicentre randomised clinical trial","volume":"132","author":"Papastefanou","year":"2025","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2026.103404_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.218","article-title":"Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks\u2019 gestation","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2026.103404_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/AOG.0000000000006100","article-title":"Comparison of 162 mg and 81 mg aspirin for prevention of preeclampsia: a randomized controlled trial","volume":"147","author":"Khander","year":"2026","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2026.103404_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2023.0691","article-title":"Aspirin discontinuation at 24 to 28 weeks\u2019 gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial","volume":"329","author":"Mendoza","year":"2023","journal-title":"JAMA"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216326002069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216326002069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:26:53Z","timestamp":1786022813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216326002069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1701216326002069"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2026.103404","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could Aspirin Be a Protective Factor and a Factor Promoting Placental Abruption?","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2026.103404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Inc. on behalf of The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada.","name":"copyright","label":"Copyright"}],"article-number":"103404"}}